Jagsonpal Pharmaceuticals (India) Analysis

Jagsonpal Stock Analysis Notes

About 76.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 8.99. Jagsonpal Pharmaceuticals last dividend was issued on the 6th of September 2024. The entity had 2.5:1 split on the 8th of January 2025. To learn more about Jagsonpal Pharmaceuticals Limited call the company at 91 12 4440 6710 or check out https://www.jagsonpal.com.

Jagsonpal Pharmaceuticals Investment Alerts

Jagsonpal Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 16.9 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jagsonpal Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Jagsonpal Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Jagsonpal Profitablity

The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19.

Management Efficiency

Jagsonpal Pharmaceuticals has return on total asset (ROA) of 0.0605 % which means that it generated a profit of $0.0605 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1326 %, meaning that it generated $0.1326 on every $100 dollars invested by stockholders. Jagsonpal Pharmaceuticals' management efficiency ratios could be used to measure how well Jagsonpal Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Jagsonpal Pharmaceuticals' Non Currrent Assets Other are decreasing as compared to previous years. The Jagsonpal Pharmaceuticals' current Other Current Assets is estimated to increase to about 381.4 M, while Total Assets are projected to decrease to under 1.7 B.

Technical Drivers

As of the 25th of December, Jagsonpal Pharmaceuticals retains the Downside Deviation of 3.07, risk adjusted performance of 0.1527, and Market Risk Adjusted Performance of 0.766. Jagsonpal Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Jagsonpal Pharmaceuticals Price Movement Analysis

Jagsonpal Pharmaceuticals Outstanding Bonds

Jagsonpal Pharmaceuticals Predictive Daily Indicators

Jagsonpal Pharmaceuticals Forecast Models

Jagsonpal Pharmaceuticals' time-series forecasting models are one of many Jagsonpal Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jagsonpal Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Jagsonpal Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jagsonpal shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jagsonpal Pharmaceuticals. By using and applying Jagsonpal Stock analysis, traders can create a robust methodology for identifying Jagsonpal entry and exit points for their positions.

When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.